Maze Therapeutics President, R&D and CMO Harold Bernstein sells 16,141 common shares worth $425,392.65 - MAZE News | RalliesMaze Therapeutics President, R&D and CMO Harold Bernstein sells 16,141 common shares worth $425,392.65
M
MAZE• Harold Bernstein reports same-day exercise and sale
- Harold Bernstein, President, R&D & CMO, reported a same-day exercise and sale in Maze Therapeutics common stock on Sept. 1, 2026.
- Exercised stock options for 16,141 shares at USD 10.42.
- Sold 16,141 shares at an average USD 26.36, ending with zero shares owned directly.
- Also acquired 20,000 shares via restricted stock units at no cost, ending with 20,000 shares held.
- Derivative holdings reported at 160,662 stock options plus 20,000 restricted stock units following the transactions.
GOSS
•
